Annual General Meeting 2025
Company Announcement no. 04/2025 Annual General Meeting 2025 Copenhagen, April 1, 2025…
Total number of shares and voting rights in Zealand Pharma as of March 31, 2025
March 31, 2025 17:00 ET | Source: Zealand Pharma Company announcement –…
Rail India Conference & Expo 2025: Driving India’s Railway Revolution Towards a Green, Safe & Modern Future
Indian Railways is undergoing a remarkable transformation, driven by initiatives like electrification,…
Gartner Names DXC Technology a Leader in the 2025 Magic Quadrant for Outsourced Digital Workplace Services
DXC recognized as a leader for third consecutive year, serving more than…
Ragnarok Landverse: Genesis Grand Launch Set for March 29, 2025
SINGAPORE, March 31, 2025 /PRNewswire/ -- The wait is almost over! Ragnarok…
Shah Rukh Khan’s D’YAVOL INCEPTION Wins Gold at the Berlin International Spirits Competition 2025
With back-to-back gold medals, D'YAVOL INCEPTION continues its winning streak MUMBAI, India,…
Reaffirming Leadership: Medit’s Strong Presence at IDS 2025
COLOGNE, Germany and SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Medit,…
Wynn Hosts Grand Ceremony for the 2025 Wynn Signature Chinese Wine Awards on April 11
Close to 900 wines compete for top honors as Wynn promotes Chinese wines…
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
PARIS and CAMBRIDGE, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext:…
Novo Nordisk A/S: Rybelsus (oral semaglutide 14 mg) demonstrates superior reduction in cardiovascular events in the SOUL trial at ACC 2025
Rybelsus® reduced major adverse cardiovascular events by 14% vs placebo in adults…